Skip to content
OpenCapital
Get started

Ultragenyx Pharmaceutical RARE Current ratio

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.5×+0.1×
Amgen logo
AmgenAMGN
1.3×+0.1×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
4.1×-5.6×
Arrowhead Research logo
Arrowhead ResearchARWR
6.2×+1.1×
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
18×+2.3×
Moderna logo
ModernaMRNA
2.4×-1.8×

Other financials

Income statement

See full
Revenue$136.0M-2.2%
Operating income-$169.0M-18.2%
Net income-$185.0M-22.5%
EPS (diluted)-$1.84-17.2%

Balance sheet

See full
Cash & equivalents$175.0M+37.8%
Total debt$36.0M-10.8%
Total equity-$236.0M-264%
Total assets$1.3B-1.2%

Cash flow

See full
Operating cash flow-$197.0M-18.7%
CapEx$1.0M0.0%
Free cash flow-$198.0M-18.6%

Valuation

See full
Market cap$2.83B-39.4%
P/S4.2×-3.7×

Profitability

See full
Gross margin97.2%—
Operating margin-83.8%-3.0pp
Net margin-90.9%-2.1pp
FCF margin-75.1%+10.7pp

Returns & leverage

See full
Return on equity-325.6%+36.9pp
Debt / equity3.7×—

Where this comes from

Calculated from Ultragenyx Pharmaceutical’s reported figures.

total current assets/total current liabilities=2×

Based on the most recent quarter.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's current ratio?
Ultragenyx Pharmaceutical (RARE) reported current ratio of 2× in Q1 2026.
How has Ultragenyx Pharmaceutical's current ratio changed year-over-year?
Ultragenyx Pharmaceutical's current ratio decreased by 15.7% year-over-year, from 2.4× to 2×.
What is the long-term trend for Ultragenyx Pharmaceutical's current ratio?
Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's current ratio has grown at a -18.4% compound annual growth rate (CAGR), from 6.8× to 2.5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.